Subgroups | Categories | Point estimate Relative risk | Confidence interval Relative risk | ||
---|---|---|---|---|---|
≤0.94 | >0.94 | ≤0.75 | >0.75 | ||
Study size (in patient years) | <2000 patient-years (n = 35) | 16 (46%) | 19 (54%) | 25 (71%) | 10 (29%) |
≥2000 patient-years (n = 57) | 28 (49%) | 29 (51%) | 16 (28%) | 41 (72%) | |
Primary versus secondary prevention | Primary (n = 13) | 5 (38%) | 8 (62%) | 5 (38%) | 8 (62%) |
Secondary (n = 79) | 39 (49%) | 40 (51%) | 36 (46%) | 43 (54%) | |
≤0.85 | >0.85 | ≤0.65 | >0.65 | ||
Increase in potentially clinically meaningful thresholds (n = 92) | 16 (17%) | 76 (83%) | 22 (24%) | 70 (76%) |